A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Public ClinicalTrials.gov record NCT04660539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Single Arm, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Study identification
- NCT ID
- NCT04660539
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 119 participants
Conditions and interventions
Conditions
Interventions
- azathioprine (AZA) Drug
- mycophenolate mofetil (MMF) Drug
- oral corticosteroids Drug
- satralizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 1, 2021
- Primary completion
- May 27, 2024
- Completion
- May 27, 2024
- Last update posted
- Dec 26, 2024
2021 – 2024
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital of Alabama | Birmingham | Alabama | 35233 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Columbus Research and Wellness | Columbus | Georgia | 31909 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Consultants in Neurology Ltd | Northbrook | Illinois | 60062 | — |
| OSF Saint Francis Medical Center | Peoria | Illinois | 64637 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Wayne State University; UHC-4H | Detroit | Michigan | 48201 | — |
| The Neurological Institute PA | Charlotte | North Carolina | 28204 | — |
| OhioHealth Research Institute | Columbus | Ohio | 43214 | — |
| Jefferson Hospital For Neuroscience; Jefferson Neurology Associates | Philadelphia | Pennsylvania | 19107 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-0001 | — |
| Central Texas Neurology Consultants | Round Rock | Texas | 78681 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04660539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 26, 2024 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04660539 live on ClinicalTrials.gov.